During the CRC development in the APCmin/+ mouse model, CD4+Foxp3+ Treg cells accumulate in the adenomas, which match with lower frequencies of conventional T and B cells in situ [69], indicating a downmodulation of the local immune response against CRC. This evidence concerns the gene FOXP3 and colorectal carcinoma.